![Yifan Zhai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yifan Zhai
Chief Tech/Sci/R&D Officer at
ASCENTAGE PHARMA GROUP INTERNATIONAL
Net worth: 163 M $ as of 2026-07-30
Profile
Yifan Zhai is currently Chief Medical Officer at Ascentage Pharma Group International Co., Ltd. since 2013.
Former positions include Director of the Pharmacology Department at Exelixis, Inc. from 2001 to 2003; Principal at Human Genome Sciences, Inc.; Chief Scientific Officer at Celladon Corp.
from 2007 to 2010; Principal at Bayer Pharmaceuticals Corp.; President of HealthQuest, Inc. from 2003 to 2005; President of The Chinese Biopharmaceutical Association from 2009 to 2010; and Chief Scientific Officer at Oncomax Acquisition Corp.
from 2005 to 2007.
Education includes doctorates from Michigan State University in 1993 and Sun Yat-Sen University in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-20 | 37,742,091 ( 10.1% ) | 163 M $ | 2026-07-30 |
Yifan Zhai active positions
| Companies | Position | Start |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Chief Tech/Sci/R&D Officer | 2013-06-30 |
Former positions of Yifan Zhai
| Companies | Position | End |
|---|---|---|
The Chinese Biopharmaceutical Association | President | 2009-12-31 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Oncomax Acquisition Corp. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
HealthQuest, Inc.
 HealthQuest, Inc. Medical/Nursing ServicesHealth Services Provides health care and well-being awareness services | President | 2004-12-31 |
| EXELIXIS, INC. | Corporate Officer/Principal | 2002-12-31 |
Training of Yifan Zhai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
Bayer Pharmaceuticals Corp. | |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HealthQuest, Inc.
HealthQuest, Inc. Medical/Nursing ServicesHealth Services Provides health care and well-being awareness services | Health Services |
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese Biopharmaceutical Association | |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Oncomax Acquisition Corp. |
- Stock Market
- Insiders
- Yifan Zhai
